Jinfeng Zhang

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Disitamab vedotin in combination with lenvatinib for patients with HER2-positive unresectable locally advanced or metastatic biliary tract cancer: study protocol of a phase II clinical trial.

Disitamab vedotin in combination with lenvatinib for patients with HER2-positive unresectable locally advanced or metastatic biliary tract cancer: study protocol of a phase II clinical trial.

Journal: BMJ open

Published: January 08, 2026

Anti-infection and healing promotion of skin ECM hydrogel.

Anti-infection and healing promotion of skin ECM hydrogel.

Journal: Cutaneous and ocular toxicology

Published: November 19, 2025

Self-Foaming, Oil-Absorbable, Flame Self-Extinguishing and Thermal Insulation POSS/PDMS Foams.

Self-Foaming, Oil-Absorbable, Flame Self-Extinguishing and Thermal Insulation POSS/PDMS Foams.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: August 31, 2025

Safety and efficacy of JWATM204, a novel Glypican-3 (GPC3)-targeted CAR T cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation study.

Safety and efficacy of JWATM204, a novel Glypican-3 (GPC3)-targeted CAR T cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation study.

Journal: Cancer pathogenesis and therapy

Published: June 26, 2025

Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial.

Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial.

Journal: Nature communications

Published: February 09, 2025

Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial.

Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial.

Journal: BMJ open

Published: June 10, 2024

Water-Soluble, Self-Healing, and Debonding Primer for the Interface between Silicone Leather and Polydimethylsiloxane Composites.

Water-Soluble, Self-Healing, and Debonding Primer for the Interface between Silicone Leather and Polydimethylsiloxane Composites.

Journal: Langmuir : the ACS journal of surfaces and colloids

Published: May 23, 2024

Flexible transparent and hydrophobic SiNCs/PDMS coatings for anti-counterfeiting applications.

Flexible transparent and hydrophobic SiNCs/PDMS coatings for anti-counterfeiting applications.

Journal: Materials horizons

Published: May 15, 2024

Luminescent Mechanism and Anti-Counterfeiting Application of Hydrophilic, Undoped Room-Temperature Phosphorescent Silicon Nanocrystals.

Luminescent Mechanism and Anti-Counterfeiting Application of Hydrophilic, Undoped Room-Temperature Phosphorescent Silicon Nanocrystals.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: April 25, 2023

The Heuristic Algorithm Optimization of Home Care Path Based on the Internet of Things Realizes Connected Medical Care.

The Heuristic Algorithm Optimization of Home Care Path Based on the Internet of Things Realizes Connected Medical Care.

Journal: Computational and mathematical methods in medicine

Published: December 22, 2021

Comparison of anti-EGFR-Fab' conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cells.

Comparison of anti-EGFR-Fab' conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cells.

Journal: International journal of nanomedicine

Published: September 12, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026